172 related articles for article (PubMed ID: 37052977)
1. A Novel Capacity-Strengthening Intervention for Frontline Harm Reduction Workers to Support Pre-exposure Prophylaxis Awareness-Building and Promotion Among People Who Use Drugs: Formative Research and Intervention Development.
Glick JL; Zhang L; Rosen JG; Yaroshevich K; Atiba B; Pelaez D; Park JN
JMIR Form Res; 2023 Apr; 7():e42418. PubMed ID: 37052977
[TBL] [Abstract][Full Text] [Related]
2. A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation.
Rosen JG; Zhang L; Pelaez D; Park JN; Glick JL
AIDS Behav; 2023 Jul; 27(7):2440-2453. PubMed ID: 36596866
[TBL] [Abstract][Full Text] [Related]
3. Pre-exposure prophylaxis (PrEP) among people who use drugs: a qualitative scoping review of implementation determinants and change methods.
Merle JL; Zapata JP; Quieroz A; Zamantakis A; Sanuade O; Mustanski B; Smith JD
Addict Sci Clin Pract; 2024 May; 19(1):46. PubMed ID: 38816889
[TBL] [Abstract][Full Text] [Related]
4. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
Davitadze A; Meylakhs P; Lakhov A; King EJ
Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
[TBL] [Abstract][Full Text] [Related]
5. The PEARL study: a prospective two-group pilot PrEP promotion intervention for cisgender female sex workers living in Baltimore, MD, U.S.
Pelaez D; Weicker NP; Glick J; Mesenburg JV; Wilson A; Kirkpatrick H; Clouse E; Sherman SG
AIDS Care; 2021; 33(sup1):1-10. PubMed ID: 33627006
[TBL] [Abstract][Full Text] [Related]
6. Correction to: A Capacity-Strengthening Intervention to Support HIV Pre-exposure Prophylaxis (PrEP) Awareness-Building and Promotion by Frontline Harm Reduction Workers in Baltimore, Maryland: A Mixed Methods Evaluation.
Rosen JG; Zhang L; Pelaez D; Park JN; Glick JL
AIDS Behav; 2023 Jul; 27(7):2454. PubMed ID: 36723771
[No Abstract] [Full Text] [Related]
7. Empowering With PrEP (E-PrEP), a Peer-Led Social Media-Based Intervention to Facilitate HIV Preexposure Prophylaxis Adoption Among Young Black and Latinx Gay and Bisexual Men: Protocol for a Cluster Randomized Controlled Trial.
Patel VV; Ginsburg Z; Golub SA; Horvath KJ; Rios N; Mayer KH; Kim RS; Arnsten JH
JMIR Res Protoc; 2018 Aug; 7(8):e11375. PubMed ID: 30154071
[TBL] [Abstract][Full Text] [Related]
8. Awareness about and willingness to use long-acting injectable pre-exposure prophylaxis (LAI-PrEP) among people who use drugs.
Shrestha R; DiDomizio EE; Kim RS; Altice FL; Wickersham JA; Copenhaver MM
J Subst Abuse Treat; 2020 Oct; 117():108058. PubMed ID: 32811633
[TBL] [Abstract][Full Text] [Related]
9. Using PrEP and Doing it for Ourselves (UPDOs Protective Styles), a Web-Based Salon Intervention to Improve Uptake of Pre-exposure Prophylaxis Among Black Women: Protocol for a Pilot Feasibility Study.
Randolph SD; Johnson R; Johnson A; Keusch L
JMIR Res Protoc; 2022 Aug; 11(8):e34556. PubMed ID: 36040785
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of microbicidal vaginal rings and oral pre-exposure prophylaxis for HIV prevention among female sex workers in a high-prevalence US city.
Peitzmeier SM; Tomko C; Wingo E; Sawyer A; Sherman SG; Glass N; Beyrer C; Decker MR
AIDS Care; 2017 Nov; 29(11):1453-1457. PubMed ID: 28271718
[TBL] [Abstract][Full Text] [Related]
11. Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives.
Surratt HL; Yeager HJ; Adu A; González EA; Nelson EO; Walker T
Front Psychiatry; 2022; 13():905314. PubMed ID: 35706473
[TBL] [Abstract][Full Text] [Related]
12. Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.
Shrestha R; Altice FL; Sibilio B; Ssenyonjo J; Copenhaver MM
Contemp Clin Trials; 2019 Jul; 82():77-84. PubMed ID: 31229618
[TBL] [Abstract][Full Text] [Related]
13. Barriers and facilitators to pre-exposure prophylaxis uptake among male sex workers in Mexico: an application of the RE-AIM framework.
Kadiamada-Ibarra H; Hawley NL; Sosa-Rubí SG; Wilson-Barthes M; Franco RR; Galárraga O
BMC Public Health; 2021 Nov; 21(1):2174. PubMed ID: 34837988
[TBL] [Abstract][Full Text] [Related]
14. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
15. Cultivating PEARL (Promoting Empowerment and Risk Reduction): Formative Research for a PrEP Intervention Among Female Sex Workers in Baltimore, Maryland.
Glick JL; Jivapong B; Russo R; Pelaez D; Piser R; Footer K; Sherman SG
AIDS Behav; 2022 Aug; 26(8):2664-2675. PubMed ID: 35124751
[TBL] [Abstract][Full Text] [Related]
16. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
[TBL] [Abstract][Full Text] [Related]
17. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.
Mack N; Odhiambo J; Wong CM; Agot K
BMC Health Serv Res; 2014 May; 14():231. PubMed ID: 24886646
[TBL] [Abstract][Full Text] [Related]
18. Integrating and Disseminating Pre-Exposure Prophylaxis (PrEP) Screening and Dispensing for Black Men Who Have Sex With Men in Atlanta, Georgia: Protocol for Community Pharmacies.
Crawford ND; Harrington KRV; Alohan DI; Sullivan PS; Holland DP; Klepser DG; Quamina A; Siegler AJ; Young HN
JMIR Res Protoc; 2022 Feb; 11(2):e35590. PubMed ID: 35138252
[TBL] [Abstract][Full Text] [Related]
19. The Past, Present, and Future of PrEP implementation Among People Who Use Drugs.
Biello KB; Mimiaga MJ; Valente PK; Saxena N; Bazzi AR
Curr HIV/AIDS Rep; 2021 Aug; 18(4):328-338. PubMed ID: 33907971
[TBL] [Abstract][Full Text] [Related]
20. Online HIV information seeking and pre-exposure prophylaxis awareness among people who use drugs.
Ranjit YS; Shrestha R; Copenhaver M; Altice FL
J Subst Abuse Treat; 2020 Apr; 111():16-22. PubMed ID: 32087834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]